APO Research
Talk to an analyst

APO RESEARCH · REPORT

Over-the-Counter Drugs

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Over-the-Counter Drugs Market Outlook and Growth Opportunities 2026

26 December 2025194 pages

Choose your research edition.

Industry ResearchOver-the-Counter Drugs Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Over-the-Counter Drugs Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Over-the-Counter Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Over-the-Counter Drugs Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Over-the-Counter Drugs Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Over-the-Counter Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Over-the-Counter Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Over-the-Counter Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Over-the-Counter Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Over-the-Counter Drugs market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Over-the-Counter Drugs market include Teva Pharmaceutical Industries, Sanofi, Johnson & Johnson, Novartis, Merck, Pfizer, GlaxoSmithKline, Bayer and Sun Pharmaceutical Industries, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Over-the-Counter Drugs market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Over-the-Counter Drugs and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Over-the-Counter Drugs revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Over-the-Counter Drugs market.

Over-the-Counter Drugs Segment by Company

Teva Pharmaceutical Industries

Sanofi

Johnson & Johnson

Novartis

Merck

Pfizer

GlaxoSmithKline

Bayer

Sun Pharmaceutical Industries

Glenmark Pharmaceuticals

Cipla

Boehringer Ingelheim

Alkem Laboratories

Over-the-Counter Drugs Segment by Type

Cough, Cold and Flu Products

Weight Loss Products

Smoking Cession Aids

Dermatological Products

Sleep Aids

Vitamin & Mineral Supplements

Gastrointestinal Products

Ophthalmic Products

Analgesics & Pain Relievers

Other

Over-the-Counter Drugs Segment by Application

Hospital Pharmacies

Online Pharmacies

Retail Pharmacies

Over-the-Counter Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Over-the-Counter Drugs status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Over-the-Counter Drugs key companies, revenue, market share, and recent developments.

3. To split the Over-the-Counter Drugs breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Over-the-Counter Drugs market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Over-the-Counter Drugs significant trends, drivers, influence factors in global and regions.

6. To analyze Over-the-Counter Drugs competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Over-the-Counter Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Over-the-Counter Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Over-the-Counter Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Over-the-Counter Drugs industry.

Chapter 3: Detailed analysis of Over-the-Counter Drugs company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Over-the-Counter Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Over-the-Counter Drugs in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Over-the-Counter Drugs Industry Trends Table 2. Over-the-Counter Drugs Industry Drivers Table 3. Over-the-Counter Drugs Industry Opportunities and Challenges Table 4. Over-the-Counter Drugs Industry Restraints Table 5. Global Over-the-Counter Drugs Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Over-the-Counter Drugs Revenue Share by Company (2021-2026) Table 7. Global Over-the-Counter Drugs Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Over-the-Counter Drugs Key Company Manufacturing Base & Headquarters Table 9. Global Over-the-Counter Drugs Company, Product Type & Application Table 10. Global Over-the-Counter Drugs Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Over-the-Counter Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Cough, Cold and Flu Products Table 15. Significant Companies of Weight Loss Products Table 16. Significant Companies of Smoking Cession Aids Table 17. Significant Companies of Dermatological Products Table 18. Significant Companies of Sleep Aids Table 19. Significant Companies of Vitamin & Mineral Supplements Table 20. Significant Companies of Gastrointestinal Products Table 21. Significant Companies of Ophthalmic Products Table 22. Significant Companies of Analgesics & Pain Relievers Table 23. Significant Companies of Other Table 24. Global Over-the-Counter Drugs Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Over-the-Counter Drugs Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Over-the-Counter Drugs Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Over-the-Counter Drugs Sales Value Share by Type (2021-2026) Table 28. Global Over-the-Counter Drugs Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Hospital Pharmacies Table 30. Significant Companies of Online Pharmacies Table 31. Significant Companies of Retail Pharmacies Table 32. Global Over-the-Counter Drugs Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Over-the-Counter Drugs Sales Value by Application (2021-2026) & (US$ Million) Table 34. Global Over-the-Counter Drugs Sales Value by Application (2027-2032) & (US$ Million) Table 35. Global Over-the-Counter Drugs Sales Value Share by Application (2021-2026) Table 36. Global Over-the-Counter Drugs Sales Value Share by Application (2027-2032) Table 37. Global Over-the-Counter Drugs Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Over-the-Counter Drugs Sales Value by Region (2021-2026) & (US$ Million) Table 39. Global Over-the-Counter Drugs Sales Value Share by Region (2021-2026) Table 40. Global Over-the-Counter Drugs Sales Value by Region (2027-2032) & (US$ Million) Table 41. Global Over-the-Counter Drugs Sales Value Share by Region (2027-2032) Table 42. Global Over-the-Counter Drugs Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 43. Global Over-the-Counter Drugs Sales Value by Country (2021-2026) & (US$ Million) Table 44. Global Over-the-Counter Drugs Sales Value Market Share by Country (2021-2026) Table 45. Global Over-the-Counter Drugs Sales Value by Country (2027-2032) & (US$ Million) Table 46. Global Over-the-Counter Drugs Sales Value Market Share by Country (2027-2032) Table 47. Teva Pharmaceutical Industries Company Information Table 48. Teva Pharmaceutical Industries Business Overview Table 49. Teva Pharmaceutical Industries Over-the-Counter Drugs Revenue (US$ Million) and Gross Margin (2021-2026) Table 50. Teva Pharmaceutical Industries Over-the-Counter Drugs Product Portfolio Table 51. Teva Pharmaceutical Industries Recent Development Table 52. Sanofi Company Information Table 53. Sanofi Business Overview Table 54. Sanofi Over-the-Counter Drugs Revenue (US$ Million) and Gross Margin (2021-2026) Table 55. Sanofi Over-the-Counter Drugs Product Portfolio Table 56. Sanofi Recent Development Table 57. Johnson & Johnson Company Information Table 58. Johnson & Johnson Business Overview Table 59. Johnson & Johnson Over-the-Counter Drugs Revenue (US$ Million) and Gross Margin (2021-2026) Table 60. Johnson & Johnson Over-the-Counter Drugs Product Portfolio Table 61. Johnson & Johnson Recent Development Table 62. Novartis Company Information Table 63. Novartis Business Overview Table 64. Novartis Over-the-Counter Drugs Revenue (US$ Million) and Gross Margin (2021-2026) Table 65. Novartis Over-the-Counter Drugs Product Portfolio Table 66. Novartis Recent Development Table 67. Merck Company Information Table 68. Merck Business Overview Table 69. Merck Over-the-Counter Drugs Revenue (US$ Million) and Gross Margin (2021-2026) Table 70. Merck Over-the-Counter Drugs Product Portfolio Table 71. Merck Recent Development Table 72. Pfizer Company Information Table 73. Pfizer Business Overview Table 74. Pfizer Over-the-Counter Drugs Revenue (US$ Million) and Gross Margin (2021-2026) Table 75. Pfizer Over-the-Counter Drugs Product Portfolio Table 76. Pfizer Recent Development Table 77. GlaxoSmithKline Company Information Table 78. GlaxoSmithKline Business Overview Table 79. GlaxoSmithKline Over-the-Counter Drugs Revenue (US$ Million) and Gross Margin (2021-2026) Table 80. GlaxoSmithKline Over-the-Counter Drugs Product Portfolio Table 81. GlaxoSmithKline Recent Development Table 82. Bayer Company Information Table 83. Bayer Business Overview Table 84. Bayer Over-the-Counter Drugs Revenue (US$ Million) and Gross Margin (2021-2026) Table 85. Bayer Over-the-Counter Drugs Product Portfolio Table 86. Bayer Recent Development Table 87. Sun Pharmaceutical Industries Company Information Table 88. Sun Pharmaceutical Industries Business Overview Table 89. Sun Pharmaceutical Industries Over-the-Counter Drugs Revenue (US$ Million) and Gross Margin (2021-2026) Table 90. Sun Pharmaceutical Industries Over-the-Counter Drugs Product Portfolio Table 91. Sun Pharmaceutical Industries Recent Development Table 92. Glenmark Pharmaceuticals Company Information Table 93. Glenmark Pharmaceuticals Business Overview Table 94. Glenmark Pharmaceuticals Over-the-Counter Drugs Revenue (US$ Million) and Gross Margin (2021-2026) Table 95. Glenmark Pharmaceuticals Over-the-Counter Drugs Product Portfolio Table 96. Glenmark Pharmaceuticals Recent Development Table 97. Cipla Company Information Table 98. Cipla Business Overview Table 99. Cipla Over-the-Counter Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Cipla Over-the-Counter Drugs Product Portfolio Table 101. Cipla Recent Development Table 102. Boehringer Ingelheim Company Information Table 103. Boehringer Ingelheim Business Overview Table 104. Boehringer Ingelheim Over-the-Counter Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Boehringer Ingelheim Over-the-Counter Drugs Product Portfolio Table 106. Boehringer Ingelheim Recent Development Table 107. Alkem Laboratories Company Information Table 108. Alkem Laboratories Business Overview Table 109. Alkem Laboratories Over-the-Counter Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. Alkem Laboratories Over-the-Counter Drugs Product Portfolio Table 111. Alkem Laboratories Recent Development Table 112. Research Programs/Design for This Report Table 113. Authors List of This Report Table 114. Secondary Sources Table 115. Primary Sources List of Figures Figure 1. Over-the-Counter Drugs Product Image Figure 2. Global Over-the-Counter Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Over-the-Counter Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Over-the-Counter Drugs Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Cough, Cold and Flu Products Image Figure 8. Weight Loss Products Image Figure 9. Smoking Cession Aids Image Figure 10. Dermatological Products Image Figure 11. Sleep Aids Image Figure 12. Vitamin & Mineral Supplements Image Figure 13. Gastrointestinal Products Image Figure 14. Ophthalmic Products Image Figure 15. Analgesics & Pain Relievers Image Figure 16. Other Image Figure 17. Global Over-the-Counter Drugs Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Over-the-Counter Drugs Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Over-the-Counter Drugs Sales Value Share by Type (2021-2032) Figure 20. Hospital Pharmacies Image Figure 21. Online Pharmacies Image Figure 22. Retail Pharmacies Image Figure 23. Global Over-the-Counter Drugs Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Over-the-Counter Drugs Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Over-the-Counter Drugs Sales Value Share by Application (2021-2032) Figure 26. Global Over-the-Counter Drugs Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 27. Global Over-the-Counter Drugs Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 28. North America Over-the-Counter Drugs Sales Value (2021-2032) & (US$ Million) Figure 29. North America Over-the-Counter Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 30. Europe Over-the-Counter Drugs Sales Value (2021-2032) & (US$ Million) Figure 31. Europe Over-the-Counter Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Asia-Pacific Over-the-Counter Drugs Sales Value (2021-2032) & (US$ Million) Figure 33. Asia-Pacific Over-the-Counter Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 34. South America Over-the-Counter Drugs Sales Value (2021-2032) & (US$ Million) Figure 35. South America Over-the-Counter Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Middle East & Africa Over-the-Counter Drugs Sales Value (2021-2032) & (US$ Million) Figure 37. Middle East & Africa Over-the-Counter Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 38. USA Over-the-Counter Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. USA Over-the-Counter Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. USA Over-the-Counter Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Canada Over-the-Counter Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Canada Over-the-Counter Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Canada Over-the-Counter Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Mexico Over-the-Counter Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Mexico Over-the-Counter Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Mexico Over-the-Counter Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Germany Over-the-Counter Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Germany Over-the-Counter Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Germany Over-the-Counter Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. France Over-the-Counter Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. France Over-the-Counter Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. France Over-the-Counter Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. U.K. Over-the-Counter Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. U.K. Over-the-Counter Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. U.K. Over-the-Counter Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Italy Over-the-Counter Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Italy Over-the-Counter Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Italy Over-the-Counter Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Spain Over-the-Counter Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Spain Over-the-Counter Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Spain Over-the-Counter Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Russia Over-the-Counter Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Russia Over-the-Counter Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Russia Over-the-Counter Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Netherlands Over-the-Counter Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Netherlands Over-the-Counter Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Netherlands Over-the-Counter Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Nordic Countries Over-the-Counter Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Nordic Countries Over-the-Counter Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Nordic Countries Over-the-Counter Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. China Over-the-Counter Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. China Over-the-Counter Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. China Over-the-Counter Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. Japan Over-the-Counter Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. Japan Over-the-Counter Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. Japan Over-the-Counter Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. South Korea Over-the-Counter Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. South Korea Over-the-Counter Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. South Korea Over-the-Counter Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. India Over-the-Counter Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. India Over-the-Counter Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. India Over-the-Counter Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Australia Over-the-Counter Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Australia Over-the-Counter Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Australia Over-the-Counter Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Southeast Asia Over-the-Counter Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Southeast Asia Over-the-Counter Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Southeast Asia Over-the-Counter Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Brazil Over-the-Counter Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Brazil Over-the-Counter Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Brazil Over-the-Counter Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Argentina Over-the-Counter Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Argentina Over-the-Counter Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Argentina Over-the-Counter Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Chile Over-the-Counter Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Chile Over-the-Counter Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Chile Over-the-Counter Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Colombia Over-the-Counter Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Colombia Over-the-Counter Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Colombia Over-the-Counter Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Peru Over-the-Counter Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Peru Over-the-Counter Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Peru Over-the-Counter Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Saudi Arabia Over-the-Counter Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Saudi Arabia Over-the-Counter Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Over-the-Counter Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Israel Over-the-Counter Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Israel Over-the-Counter Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Israel Over-the-Counter Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. UAE Over-the-Counter Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. UAE Over-the-Counter Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. UAE Over-the-Counter Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Turkey Over-the-Counter Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Turkey Over-the-Counter Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Turkey Over-the-Counter Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Iran Over-the-Counter Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Iran Over-the-Counter Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Iran Over-the-Counter Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Egypt Over-the-Counter Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Egypt Over-the-Counter Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Egypt Over-the-Counter Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Years Considered Figure 123. Research Process Figure 124. Key Executives Interviewed

Scope & coverage.

Types
  • Cough, Cold and Flu Products
  • Weight Loss Products
  • Smoking Cession Aids
  • Dermatological Products
  • Sleep Aids
  • Vitamin & Mineral Supplements
  • Gastrointestinal Products
  • Ophthalmic Products
  • Analgesics & Pain Relievers
  • Other
Applications
  • Hospital Pharmacies
  • Online Pharmacies
  • Retail Pharmacies
Companies covered
  • Teva Pharmaceutical Industries
  • Sanofi
  • Johnson & Johnson
  • Novartis
  • Merck
  • Pfizer
  • GlaxoSmithKline
  • Bayer
  • Sun Pharmaceutical Industries
  • Glenmark Pharmaceuticals
  • Cipla
  • Boehringer Ingelheim
  • Alkem Laboratories

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Over-the-Counter Drugs Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Over-the-Counter Drugs Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Over-the-Counter Drugs Market Dynamics
  1. 2.1 Over-the-Counter Drugs Industry Trends
  2. 2.2 Over-the-Counter Drugs Industry Drivers
  3. 2.3 Over-the-Counter Drugs Industry Opportunities and Challenges
  4. 2.4 Over-the-Counter Drugs Industry Restraints
3 Over-the-Counter Drugs Market by Company
  1. 3.1 Global Over-the-Counter Drugs Company Revenue Ranking in 2025
  2. 3.2 Global Over-the-Counter Drugs Revenue by Company (2021-2026)
  3. 3.3 Global Over-the-Counter Drugs Company Ranking (2024-2026)
  4. 3.4 Global Over-the-Counter Drugs Company Manufacturing Base and Headquarters
  5. 3.5 Global Over-the-Counter Drugs Company Product Type and Application
  6. 3.6 Global Over-the-Counter Drugs Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Over-the-Counter Drugs Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Over-the-Counter Drugs Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Over-the-Counter Drugs Market by Type
  1. 4.1 Over-the-Counter Drugs Type Introduction
  2. 4.1.1 Cough, Cold and Flu Products
  3. 4.1.2 Weight Loss Products
  4. 4.1.3 Smoking Cession Aids
  5. 4.1.4 Dermatological Products
  6. 4.1.5 Sleep Aids
  7. 4.1.6 Vitamin & Mineral Supplements
  8. 4.1.7 Gastrointestinal Products
  9. 4.1.8 Ophthalmic Products
  10. 4.1.9 Analgesics & Pain Relievers
  11. 4.1.10 Other
  12. 4.2 Global Over-the-Counter Drugs Sales Value by Type
  13. 4.2.1 Global Over-the-Counter Drugs Sales Value by Type (2021 VS 2025 VS 2032)
  14. 4.2.2 Global Over-the-Counter Drugs Sales Value by Type (2021-2032)
  15. 4.2.3 Global Over-the-Counter Drugs Sales Value Share by Type (2021-2032)
5 Over-the-Counter Drugs Market by Application
  1. 5.1 Over-the-Counter Drugs Application Introduction
  2. 5.1.1 Hospital Pharmacies
  3. 5.1.2 Online Pharmacies
  4. 5.1.3 Retail Pharmacies
  5. 5.2 Global Over-the-Counter Drugs Sales Value by Application
  6. 5.2.1 Global Over-the-Counter Drugs Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Over-the-Counter Drugs Sales Value by Application (2021-2032)
  8. 5.2.3 Global Over-the-Counter Drugs Sales Value Share by Application (2021-2032)
6 Over-the-Counter Drugs Regional Value Analysis
  1. 6.1 Global Over-the-Counter Drugs Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Over-the-Counter Drugs Sales Value by Region (2021-2032)
  3. 6.2.1 Global Over-the-Counter Drugs Sales Value by Region: 2021-2026
  4. 6.2.2 Global Over-the-Counter Drugs Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Over-the-Counter Drugs Sales Value (2021-2032)
  7. 6.3.2 North America Over-the-Counter Drugs Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Over-the-Counter Drugs Sales Value (2021-2032)
  10. 6.4.2 Europe Over-the-Counter Drugs Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Over-the-Counter Drugs Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Over-the-Counter Drugs Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Over-the-Counter Drugs Sales Value (2021-2032)
  16. 6.6.2 South America Over-the-Counter Drugs Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Over-the-Counter Drugs Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Over-the-Counter Drugs Sales Value Share by Country, 2025 VS 2032
7 Over-the-Counter Drugs Country-level Value Analysis
  1. 7.1 Global Over-the-Counter Drugs Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Over-the-Counter Drugs Sales Value by Country (2021-2032)
  3. 7.2.1 Global Over-the-Counter Drugs Sales Value by Country (2021-2026)
  4. 7.2.2 Global Over-the-Counter Drugs Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Over-the-Counter Drugs Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Over-the-Counter Drugs Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Over-the-Counter Drugs Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Over-the-Counter Drugs Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Over-the-Counter Drugs Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Over-the-Counter Drugs Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Over-the-Counter Drugs Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Over-the-Counter Drugs Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Over-the-Counter Drugs Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Over-the-Counter Drugs Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Over-the-Counter Drugs Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Over-the-Counter Drugs Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Over-the-Counter Drugs Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Over-the-Counter Drugs Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Over-the-Counter Drugs Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Over-the-Counter Drugs Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Over-the-Counter Drugs Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Over-the-Counter Drugs Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Over-the-Counter Drugs Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Over-the-Counter Drugs Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Over-the-Counter Drugs Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Over-the-Counter Drugs Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Over-the-Counter Drugs Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Over-the-Counter Drugs Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Over-the-Counter Drugs Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Over-the-Counter Drugs Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Over-the-Counter Drugs Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Over-the-Counter Drugs Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Over-the-Counter Drugs Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Over-the-Counter Drugs Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Over-the-Counter Drugs Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Over-the-Counter Drugs Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Over-the-Counter Drugs Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Over-the-Counter Drugs Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Over-the-Counter Drugs Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Over-the-Counter Drugs Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Over-the-Counter Drugs Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Over-the-Counter Drugs Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Over-the-Counter Drugs Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Over-the-Counter Drugs Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Over-the-Counter Drugs Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Over-the-Counter Drugs Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Over-the-Counter Drugs Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Over-the-Counter Drugs Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Over-the-Counter Drugs Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Over-the-Counter Drugs Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Over-the-Counter Drugs Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Over-the-Counter Drugs Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Over-the-Counter Drugs Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Over-the-Counter Drugs Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Over-the-Counter Drugs Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Over-the-Counter Drugs Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Over-the-Counter Drugs Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Over-the-Counter Drugs Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Over-the-Counter Drugs Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Over-the-Counter Drugs Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Over-the-Counter Drugs Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Over-the-Counter Drugs Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Over-the-Counter Drugs Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Over-the-Counter Drugs Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Over-the-Counter Drugs Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Over-the-Counter Drugs Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Over-the-Counter Drugs Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Over-the-Counter Drugs Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Over-the-Counter Drugs Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Over-the-Counter Drugs Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Over-the-Counter Drugs Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Over-the-Counter Drugs Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Over-the-Counter Drugs Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Over-the-Counter Drugs Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Over-the-Counter Drugs Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Over-the-Counter Drugs Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Over-the-Counter Drugs Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Over-the-Counter Drugs Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Over-the-Counter Drugs Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Over-the-Counter Drugs Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Over-the-Counter Drugs Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Over-the-Counter Drugs Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Over-the-Counter Drugs Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Over-the-Counter Drugs Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Over-the-Counter Drugs Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Over-the-Counter Drugs Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Over-the-Counter Drugs Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Over-the-Counter Drugs Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Teva Pharmaceutical Industries
  2. 8.1.1 Teva Pharmaceutical Industries Company Information
  3. 8.1.2 Teva Pharmaceutical Industries Business Overview
  4. 8.1.3 Teva Pharmaceutical Industries Over-the-Counter Drugs Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Teva Pharmaceutical Industries Over-the-Counter Drugs Product Portfolio
  6. 8.1.5 Teva Pharmaceutical Industries Recent Developments
  7. 8.2 Sanofi
  8. 8.2.1 Sanofi Company Information
  9. 8.2.2 Sanofi Business Overview
  10. 8.2.3 Sanofi Over-the-Counter Drugs Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Sanofi Over-the-Counter Drugs Product Portfolio
  12. 8.2.5 Sanofi Recent Developments
  13. 8.3 Johnson & Johnson
  14. 8.3.1 Johnson & Johnson Company Information
  15. 8.3.2 Johnson & Johnson Business Overview
  16. 8.3.3 Johnson & Johnson Over-the-Counter Drugs Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Johnson & Johnson Over-the-Counter Drugs Product Portfolio
  18. 8.3.5 Johnson & Johnson Recent Developments
  19. 8.4 Novartis
  20. 8.4.1 Novartis Company Information
  21. 8.4.2 Novartis Business Overview
  22. 8.4.3 Novartis Over-the-Counter Drugs Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Novartis Over-the-Counter Drugs Product Portfolio
  24. 8.4.5 Novartis Recent Developments
  25. 8.5 Merck
  26. 8.5.1 Merck Company Information
  27. 8.5.2 Merck Business Overview
  28. 8.5.3 Merck Over-the-Counter Drugs Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Merck Over-the-Counter Drugs Product Portfolio
  30. 8.5.5 Merck Recent Developments
  31. 8.6 Pfizer
  32. 8.6.1 Pfizer Company Information
  33. 8.6.2 Pfizer Business Overview
  34. 8.6.3 Pfizer Over-the-Counter Drugs Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Pfizer Over-the-Counter Drugs Product Portfolio
  36. 8.6.5 Pfizer Recent Developments
  37. 8.7 GlaxoSmithKline
  38. 8.7.1 GlaxoSmithKline Company Information
  39. 8.7.2 GlaxoSmithKline Business Overview
  40. 8.7.3 GlaxoSmithKline Over-the-Counter Drugs Revenue and Gross Margin (2021-2026)
  41. 8.7.4 GlaxoSmithKline Over-the-Counter Drugs Product Portfolio
  42. 8.7.5 GlaxoSmithKline Recent Developments
  43. 8.8 Bayer
  44. 8.8.1 Bayer Company Information
  45. 8.8.2 Bayer Business Overview
  46. 8.8.3 Bayer Over-the-Counter Drugs Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Bayer Over-the-Counter Drugs Product Portfolio
  48. 8.8.5 Bayer Recent Developments
  49. 8.9 Sun Pharmaceutical Industries
  50. 8.9.1 Sun Pharmaceutical Industries Company Information
  51. 8.9.2 Sun Pharmaceutical Industries Business Overview
  52. 8.9.3 Sun Pharmaceutical Industries Over-the-Counter Drugs Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Sun Pharmaceutical Industries Over-the-Counter Drugs Product Portfolio
  54. 8.9.5 Sun Pharmaceutical Industries Recent Developments
  55. 8.10 Glenmark Pharmaceuticals
  56. 8.10.1 Glenmark Pharmaceuticals Company Information
  57. 8.10.2 Glenmark Pharmaceuticals Business Overview
  58. 8.10.3 Glenmark Pharmaceuticals Over-the-Counter Drugs Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Glenmark Pharmaceuticals Over-the-Counter Drugs Product Portfolio
  60. 8.10.5 Glenmark Pharmaceuticals Recent Developments
  61. 8.11 Cipla
  62. 8.11.1 Cipla Company Information
  63. 8.11.2 Cipla Business Overview
  64. 8.11.3 Cipla Over-the-Counter Drugs Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Cipla Over-the-Counter Drugs Product Portfolio
  66. 8.11.5 Cipla Recent Developments
  67. 8.12 Boehringer Ingelheim
  68. 8.12.1 Boehringer Ingelheim Company Information
  69. 8.12.2 Boehringer Ingelheim Business Overview
  70. 8.12.3 Boehringer Ingelheim Over-the-Counter Drugs Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Boehringer Ingelheim Over-the-Counter Drugs Product Portfolio
  72. 8.12.5 Boehringer Ingelheim Recent Developments
  73. 8.13 Alkem Laboratories
  74. 8.13.1 Alkem Laboratories Company Information
  75. 8.13.2 Alkem Laboratories Business Overview
  76. 8.13.3 Alkem Laboratories Over-the-Counter Drugs Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Alkem Laboratories Over-the-Counter Drugs Product Portfolio
  78. 8.13.5 Alkem Laboratories Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst